NOVARTIS FDA Approval ANDA 084735

ANDA 084735

NOVARTIS

FDA Drug Application

Application #084735

Application Sponsors

ANDA 084735NOVARTIS

Marketing Status

Discontinued001

Application Products

001CAPSULE;ORAL25MG;25MG0APRESAZIDEHYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

FDA Submissions

ORIG1AP1976-05-26
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1982-03-24
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1982-03-24
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1982-03-24
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1983-09-16
MANUF (CMC); Manufacturing (CMC)SUPPL18AP1988-11-22
MANUF (CMC); Manufacturing (CMC)SUPPL19AP1988-11-22
MANUF (CMC); Manufacturing (CMC)SUPPL20AP1988-11-22
MANUF (CMC); Manufacturing (CMC)SUPPL21AP1988-11-22
MANUF (CMC); Manufacturing (CMC)SUPPL22AP1992-04-30
LABELING; LabelingSUPPL23AP1989-03-06
MANUF (CMC); Manufacturing (CMC)SUPPL24AP1989-02-09
LABELING; LabelingSUPPL26AP1988-11-03
LABELING; LabelingSUPPL29AP1991-06-20
MANUF (CMC); Manufacturing (CMC)SUPPL30AP1992-06-18
LABELING; LabelingSUPPL31AP1992-02-21
LABELING; LabelingSUPPL32AP1992-11-04
LABELING; LabelingSUPPL33AP1993-04-07
LABELING; LabelingSUPPL34AP1996-01-30
MANUF (CMC); Manufacturing (CMC)SUPPL35AP1996-12-02
MANUF (CMC); Manufacturing (CMC)SUPPL36AP1998-11-20
MANUF (CMC); Manufacturing (CMC)SUPPL37AP1999-07-20

Submissions Property Types

SUPPL9Null0
SUPPL11Null0
SUPPL12Null0
SUPPL14Null0
SUPPL18Null0
SUPPL19Null0
SUPPL20Null0
SUPPL21Null0
SUPPL22Null0
SUPPL24Null0
SUPPL30Null0
SUPPL35Null0
SUPPL36Null0
SUPPL37Null0

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 84735
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.